CORRECTING and REPLACING Sutter Health Deploys World’s First Wearable Doppler Ultrasound Patch to Enhance Safety of ICU Patients
24 July 2024 - 4:08AM
Business Wire
Eighth paragraph of release should read: One recent study
demonstrated for every 10 FloPatch assessments performed in the
emergency department, roughly four patients will avoid potentially
dangerous fluid overload, resulting in improved patient outcomes
and significant cost savings. (instead of One recent study
demonstrated that four to five patients will avoid potentially
dangerous fluid overload in the emergency department for every 10
FloPatch assessments performed, resulting in improved patient
outcomes and significant cost savings.)
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240723843538/en/
Placed on a patient’s neck, the
hands-free FloPatch continuously assesses blood flow in the carotid
arteries, which provides a window into the left ventricle. FloPatch
then wirelessly transmits that data to a secure iOS mobile
application, providing clinicians with actionable, real-time data
at the bedside. (Photo: Business Wire)
The updated release reads:
SUTTER HEALTH DEPLOYS WORLD’S FIRST WEARABLE
DOPPLER ULTRASOUND PATCH TO ENHANCE SAFETY OF ICU PATIENTS
Flosonics Medical, a leader in wearable medical ultrasound,
today announced that Sutter Health, an integrated not-for-profit
system based in Northern California, will implement FloPatch, the
world’s first wireless, wearable Doppler ultrasound. The
FDA-cleared device gives ICU clinicians a fast, hands-free method
of assessing blood-flow at the bedside to help guide
cardiopulmonary resuscitation and fluid management in critically
ill patients.
Determining how much or how little intravenous (IV) fluid to
give a patient is one of the most urgent, complicated and
error-prone interventions in critical care. FloPatch provides a
simple, fast and consistent method for measuring changes in blood
flow and heart function related to IV fluid volume. By facilitating
greater precision in IV fluid management, FloPatch improves care
for critically ill patients, including those with septic shock,
which is the leading cause of death in U.S. hospitals.
Placed on a patient’s neck, the hands-free FloPatch continuously
assesses blood flow in the carotid arteries, which provides a
window into the left ventricle. FloPatch then wirelessly transmits
that data to a secure iOS mobile application, providing clinicians
with actionable, real-time data at the bedside.
Sutter Health will deploy FloPatch this summer in two Bay Area
medical centers (at a total of four ICUs): first at Sutter’s Eden
Medical Center in Castro Valley, Calif., and then at Sutter’s
California Pacific Medical Center in San Francisco at CPMC Van
Ness, Davies and Mission Bernal campuses.
“Sepsis, hypotension/shock and renal failure are common clinical
problems in the emergency department and ICU. FloPatch can make a
large impact on patient care by allowing goal directed care which
will prevent potentially harmful interventions and, in some cases,
may avoid the need for ICU-level care," said Kristina Kury, M.D.,
medical director of Critical Care at Sutter’s Eden Medical Center.
“I believe this technology will provide more precise, actionable
data that will allow us to optimize patient care, decrease
complications and decrease length of stay for many of our
patients.”
“Based on our early experience using FloPatch, we believe it
will be as effective in managing the care of ICU patients with
congestive heart failure and other shock conditions as with
sepsis,” said George S. Horng, M.D., medical director of Critical
Care at Sutter’s CPMC. “This is a non-invasive breakthrough that
will lead to better health outcomes for our patients.”
“We’re thrilled to partner with Sutter Health to make this
pioneering ultrasound technology available to their clinicians,”
said Joe Eibl, PhD, CEO of Flosonics Medical. “FloPatch is a new
paradigm linking physiology and resuscitation medicine. We believe
it can revolutionize treatment for critical care patients by
bringing much-needed insight to the most complex and urgent medical
scenarios.”
One recent study demonstrated for every 10 FloPatch assessments
performed in the emergency department, roughly four patients will
avoid potentially dangerous fluid overload, resulting in improved
patient outcomes and significant cost savings.
About Flosonics Medical
Flosonics Medical is a Canadian medical device company engaged
in the research and development of innovative ultrasound
technology. Founded in 2015, the company’s mission is to improve
patient care and the practice of medicine through
technology-enabled solutions and ground-breaking clinical research.
For more information please visit www.flosonicsmedical.com.
About Sutter Health
Sutter Health is a not-for-profit healthcare system dedicated to
providing comprehensive care throughout California. Committed to
health equity, community partnerships, and innovative, high-quality
patient care, Sutter Health is pursuing a bold new plan to reach
more people and make excellent healthcare more connected and
accessible. Currently serving nearly 3.5 million patients, thanks
to our dedicated team of more than 57,000 employees and clinicians,
and 12,000+ affiliated physicians, with a unified focus on
expanding care to serve more patients.
Sutter delivers exceptional and affordable care through its
hospitals, medical groups, ambulatory surgery centers, urgent care
clinics, telehealth, home health, and hospice services. Dedicated
to transforming healthcare, at Sutter Health, getting better never
stops.
Learn more about how Sutter Health is transforming healthcare at
sutterhealth.org and vitals.sutterhealth.org.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240723843538/en/
For media inquiries: rgibson@flosonicsmedical.com.